StockData
Silence Therapeutics plc logo

Silence Therapeutics plc (SLN) stock

SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$19.80−0.03 (-0.15%)

Close on Nov 16, 2026Market cap $935.48MP/E –Yield –

Silence Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Silence Therapeutics

Silence Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Silence Therapeutics figures

See a number that looks wrong?